Tandapeth, Nagpur, Maharashtra
GST No. 27AAUFN1901B1ZH
Send Email
07942966700
Search
Covid Care Medicine
Exporter of a wide range of products which include jupitavir combipack tablet, paxzen tablet zenara and molnupiravir 200 mg.Jupitavir combipack tablet
REQUEST CALLBACK
Get Best Quote
Approx. Rs 4,500 / BoxGet Latest Price
Product Details:| Strength | 150 mg + 100 mg |
| Packaging Size | 6*1 |
| Composition | Nirmatrelvir 150 + Ritonavir.100 |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Brand | jupitavir tablet |
| Manufacturer | Intas Pharmaceuticals Ltd |
Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in patients who are at risk for developing serious illness. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet
Yes! I am Interested
Paxzen tablet Zenara
REQUEST CALLBACK
Get Best Quote
Approx. Rs 11,200 / BoxGet Latest Price
Product Details:| Strength | 150 mg + 100 mg |
| Packaging Size | 30 tablet |
| Composition | Nirmatrelvir (150mg) + Ritonavir (100mg) |
| Treatment | Treatment of Coronavirus disease (COVID-19) |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Brand | Paxzen |
Paxzen Tablet is intended to treat mild-to-moderate coronavirus disease(COVID-19) in adults and children aged 12 years and older weighing at least 40 kg with a positive COVID-19 test and at risk of progression to severe disease. It reduces the ability of the coronavirus to multiply in the body.
Yes! I am Interested
Molnupiravir 200 Mg
REQUEST CALLBACK
Get Best Quote
Approx. Rs 640 / BoxGet Latest Price
Product Details:| Composition | Molnupiravir 200 |
| Composition | 200 |
| Treatment | Treatment of Mild to moderate Coronavirus disease (COVID-19) |
| Packaging size | 10 capsules |
| Brand | Molulow |
Molulow 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.
Yes! I am Interested
Looking for Covid Care Medicine ?
X
Explore More Products
Contact via E-mail
Contact via SMS
Sanjay Yadav (CEO)
Nectaar Pharma
Nectaar Pharma
622, Shanti Nagar,Shant Kutte Wale Baba Ashram, Tandapeth
Nagpur - 440002, Maharashtra, India
Nagpur - 440002, Maharashtra, India
Call Us:
© Nectaar Pharma. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited